| 000 | 01445 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517091705.0 | ||
| 264 | 0 | _c20170626 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1941-837X | ||
| 024 | 7 |
_a10.1080/13696998.2016.1179199 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBianic, Florence | |
| 245 | 0 | 0 |
_aCost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting. _h[electronic resource] |
| 260 |
_bJournal of medical economics _cSep 2016 |
||
| 300 |
_a866-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEverolimus _xeconomics |
| 650 | 0 | 4 |
_aHealth Services _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xeconomics |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 |
_aLiver Transplantation _xmethods |
| 650 | 0 | 4 | _aMarkov Chains |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTacrolimus _xeconomics |
| 700 | 1 | _aCampbell, Rosanne | |
| 700 | 1 | _aDamera, Vidya | |
| 700 | 1 | _aDe Simone, Paolo | |
| 700 | 1 | _aRoccia, Alessandro | |
| 700 | 1 | _aGregson, Jill | |
| 700 | 1 | _aRicci, Jean-Francois | |
| 773 | 0 |
_tJournal of medical economics _gvol. 19 _gno. 9 _gp. 866-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/13696998.2016.1179199 _zAvailable from publisher's website |
| 999 |
_c25928734 _d25928734 |
||